BIOHALE
LIVE

Serial Number

79285954

Owner

FRIESLANDCAMPINA NEDERLAND B.V.

Filing Date

Mar 25, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BIOHALE Trademark

Serial Number: 79285954 • Registration: 6253745

BIOHALE is a trademark filed by FRIESLANDCAMPINA NEDERLAND B.V. on March 25, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

FRIESLANDCAMPINA NEDERLAND B.V. (128 trademarks)

AMERSFOORT 3818LE , NL

Entity Type: 03

DFE PHARMA GMBH & CO. KG (16 trademarks)

KLEVER STRASSE 187
GOCH 47574 , DE

Entity Type: 28

Trademark Details

Filing Date

March 25, 2020

Registration Date

January 26, 2021

Published for Opposition

November 10, 2020

Goods & Services

Chemical and organic excipients for use in the manufacture of pharmaceutical preparations; chemical and organic compositions for use in the manufacture of pharmaceuticals; enzymes in the nature of saccharides for use in the pharmaceutical industry; carbonic hydrates for pharmaceutical purposes; amino acids for laboratory or research use; amino acids for industrial purposes

Pharmaceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for pharmaceutical purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for medical purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; hyaluronic acids for pharmaceutical purposes; hyaluronic acids for medical purposes; amino acids for pharmaceutical purposes; amino acids for medical purposes; lactose for pharmaceutical purposes

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 26, 2026 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Apr 13, 2024 NREP
CHANGE OF OWNER RECEIVED FROM IB
Mar 30, 2024 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
May 23, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 30, 2021 FICS
FINAL DISPOSITION PROCESSED
Apr 30, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 26, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 26, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 10, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 10, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 21, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 1, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 1, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 1, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 1, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 1, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 29, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 28, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 28, 2020 TROA
REFUSAL PROCESSED BY IB
Aug 7, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 22, 2020 RFCS
REFUSAL PROCESSED BY MPU
Jul 22, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 17, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jun 16, 2020 CNRT
ASSIGNED TO EXAMINER
Jun 16, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
May 26, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 22, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 21, 2020 REPR